<?xml version="1.0" encoding="UTF-8"?><!-- Generated by Broadridge Transform (tm) - http://www.broadridge.com --><!-- Created: Mon Nov 16 14:43:55 UTC 2026 --><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:common="http://www.sec.gov/edgar/common">
  <schemaVersion>X0202</schemaVersion>
<headerData>
    <submissionType>SCHEDULE 13G/A</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0000938206</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>1</amendmentNo>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>09/30/2026</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001645460</issuerCik>
        <issuerName>Cue Biopharma, Inc.</issuerName>
        <issuerCusips>
          <issuerCusipNumber>22978P205</issuerCusipNumber>
        </issuerCusips>
        <issuerPrincipalExecutiveOfficeAddress>
          <common:street1>40 Guest Street</common:street1>
          <common:city>Boston</common:city>
          <common:stateOrCountry>MA</common:stateOrCountry>
          <common:zipCode>02135</common:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(b)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>DRIEHAUS CAPITAL MANAGEMENT LLC</reportingPersonName>
      <citizenshipOrOrganization>DE</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>0</soleVotingPower>
        <sharedVotingPower>292144</sharedVotingPower>
        <soleDispositivePower>0</soleDispositivePower>
        <sharedDispositivePower>292144</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>292144</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <classPercent>4.02</classPercent>
      <typeOfReportingPerson>IV</typeOfReportingPerson>
      <comments>As of the date hereof, Driehaus Capital Management LLC has ceased being a beneficial owner of more than 5% of Cue Biopharma, Inc.</comments>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>Cue Biopharma, Inc.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>40 Guest Street, Boston, MA 02135</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>Driehaus Capital Management LLC</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>25 East Erie Street, Chicago, Illinois 60611</principalBusinessOfficeOrResidenceAddress>
        <citizenship>USA</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>N</notApplicableFlag>
        <typeOfPersonFiling>IA</typeOfPersonFiling>
      </item3>
      <item4>
        <amountBeneficiallyOwned>292144</amountBeneficiallyOwned>
        <classPercent>4.02</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>0</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>292144</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>0</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>292144</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>N</notApplicableFlag>
        <classOwnership5PercentOrLess>Y</classOwnership5PercentOrLess>
      </item5>
      <item6>
        <notApplicableFlag>Y</notApplicableFlag>
      </item6>
      <item7>
        <notApplicableFlag>Y</notApplicableFlag>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>N</notApplicableFlag>
        <certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.</certifications>
      </item10>
    </items>
    <signatureInformation>
      <reportingPersonName>DRIEHAUS CAPITAL MANAGEMENT LLC</reportingPersonName>
<!-- [WMV7][S73w8qKq5U5KnVG2S0lBpDC5Ldj3KIOnNvWXfhg8sWkxq4b2H52azVmWYXonrNdABKPQMprUk2pl9piNDEn/GYwx1bBeiXPtfjRMKuUKfcVVAbU5Fjl85irgQPzZ6GaZj2LVbTc9svmVPTOZwbjE36KmYcZrmphgekoHLb57+RtZswXWqBkJw/urHWytTyz5JbndjMDJ/Hep/bZgmsSJBjL81X7bPqJkdM9ruxWgODd8eVDcCfBUhxvUiGGk/xkeOGwEPgVvphqe/lqz669auuOg9G1oWCDazxDwNc1p+rYjBSJlni7axd0p0Cf/xd2IDe+IeoajZqZcodulpA==] CSR-->
      <signatureDetails>
        <signature>Janet McWilliams</signature>
        <title>General Counsel</title>
        <date>11/16/2026</date>
      </signatureDetails>
    </signatureInformation>
  </formData>
</edgarSubmission>
